Drug lobby wants clearer FDA rules for diet pills | Reuters:
"Over the past year, the FDA has drawn fire from some manufacturers for being too cautious in reviewing medical products, hindering U.S. innovation.'via Blog this'
They point to obesity drugs, where Arena Pharmaceuticals, Orexigen Therapeutics and Vivus have hit roadblocks in gaining approval for their diet pills because of potential safety concerns."


0 comments:
Post a Comment